Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 1—January 2022
Research

Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019

Merav Ron, Tal Brosh-Nissimov, Zinaida Korenman, Orit Treygerman, Orli Sagi, Lea Valinsky, and Assaf RokneyComments to Author 
Author affiliations: Ministry of Health, Jerusalem, Israel (M. Ron, Z. Korenman, L. Valinsky, A. Rokney); Assuta Ashdod University Hospital, Ashdod, Israel (T. Brosh-Nissimov); Ben Gurion University in the Negev, Beer Sheba, Israel (T. Brosh-Nissimov); Meuhedet Health Services, Lod, Israel (O. Treygerman); Soroka University Medical Center, Beer-Sheva, Israel (O. Sagi)

Main Article

Figure 2

Ratio of male to female case-patients with invasive group A Streptococcus (N = 2,263) for selected emm types in Israel, 2016–2019. Asterisks (*) indicate significant results (p<0.05). Double asterisks (**) indicate significant results with Fisher exact test statistic value <0.00001.

Figure 2. Ratio of male to female case-patients with invasive group A Streptococcus (N = 2,263) for selected emm types in Israel, 2016–2019. Asterisks (*) indicate significant results (p<0.05). Double asterisks (**) indicate significant results with Fisher exact test statistic value <0.00001.

Main Article

Page created: November 30, 2021
Page updated: December 20, 2021
Page reviewed: December 20, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external